“SGLT2 Inhibitor Safety Signals in FAERS Ketoacidosis and other adverse events across 154,476 spontaneous reports” (2026) Diabzen, 4(16), pp. 32–33. Available at: https://thediabzen.com/index.php/d/article/view/59 (Accessed: 28 July 2026).